B

B

BONSING , Bert

Last name: BONSING

First name: Bert

November 2014 (v1)

Journal article

Metadata-only

Guidelines for time-to-event end-point definitions in trials for pancreatic cancer. Results of the DATECAN initiative (Definition for the Assessment of Time-to-event End-points in CANcer trials)

Bonnetain, Franck Bonsing, Bert Conroy, Thierry

BACKGROUND:Using potential surrogate end-points for overall survival (OS) such as Disease-Free- (DFS) or Progression-Free Survival (PFS) is increasingly common in randomised controlled trials (RCTs). However, end-points are too often imprecisely defined which largely contributes to a lack of homogeneity across trials, hampering comparison...

Uploaded on: December 4, 2022